Gelex

Commission Implementing Decision (EU) 2015/700 of 24 April 2015 authorising the placing on the market of products containing, consisting of, or produced from genetically modified soybean MON87708 (MON-877Ø8-9) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council (notified under document C(2015) 2785) (Only the French and Dutch texts are authentic) (Text with EEA relevance)

In forceVersion 2015-04-24from 2015-04-27
Grade B

mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.

Ask Gelex about this law

Address https://gelex.eu/eli/EU/decision/2015/700@2015-04-24/en

Contents
  1. Preamble
    1. Article 1 Genetically modified organism and unique identifier
    2. Article 2 Authorisation
    3. Article 3 Labelling
    4. Article 4 Monitoring for environmental effects
    5. Article 5 Community register
    6. Article 6 Authorisation holder
    7. Article 7 Validity
    8. Article 8 Addressee
  3. ANNEX
  4. ANNEX

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 1829/2003 of the European Parliament and of the Council of 22 September 2003 on genetically modified food and feed, and in particular Articles 7(3) and 19(3) thereof,

Whereas:

(1) On 2 February 2011, Monsanto Europe S.A. submitted to the competent authority of the Netherlands an application, in accordance with Articles 5 and 17 of Regulation (EC) No 1829/2003, for the placing on the market of foods, food ingredients, and feed containing, consisting of, or produced from soybean MON87708 (the application).

(2) The application also covers the placing on the market of soybean MON87708 in products consisting of it or containing it for any other uses than food and feed as any other soybean, with the exception of cultivation.

(3) In accordance with Articles 5(5) and 17(5) of Regulation (EC) No 1829/2003, the application includes the data and information required by Annexes III and IV to Directive 2001/18/EC of the European Parliament and of the Council and information and conclusions about the risk assessment carried out in accordance with the principles set out in Annex II to Directive 2001/18/EC. It also includes a monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC.

(4) On 3 October 2013, the European Food Safety Authority (EFSA) gave a favourable opinion in accordance with Articles 6 and 18 of Regulation (EC) No 1829/2003. It concluded that soybean MON87708, as described in the application, is as safe as its non-genetically modified counterpart and reference varieties with respect to potential effects on human and animal health or the environment, in the context of its intended uses.

(5) In its opinion, EFSA considered all the specific questions and concerns raised by the Member States in the context of the consultation of the national competent authorities as provided for by Articles 6(4) and 18(4) of that Regulation.

(6) In its opinion, EFSA also concluded that the environmental monitoring plan, consisting of a general surveillance plan, submitted by the applicant is in line with the intended uses of the products.

(7) Taking into account those considerations, authorisation should be granted to the products containing, consisting of, or produced from genetically modified soybean MON87708.

(8) A unique identifier should be assigned to each genetically modified organism (hereinafter GMO) as provided for in Commission Regulation (EC) No 65/2004.

(9) On the basis of the EFSA opinion, no specific labelling requirements, other than those provided for in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, appear to be necessary for foods, food ingredients and feed containing, consisting of, or produced from soybean MON87708. However, in order to ensure the use of the products within the limits of the authorisation provided for by this Decision, the labelling of products containing or consisting of the GMO for which authorisation is requested, with the exception of food products, should be complemented by a clear indication that the products in question must not be used for cultivation.

(10) Regulation (EC) No 1830/2003 of the European Parliament and of the Council lays down labelling requirements in Article 4(6) for products containing or consisting of GMOs. Traceability requirements for products containing or consisting of GMOs are laid down in paragraphs 1 to 5 of Article 4 and those for food and feed produced from GMOs are laid down in Article 5 of that Regulation.

(11) The authorisation holder should submit annual reports on the implementation and the results of the activities set out in the monitoring plan for environmental effects. Those results should be presented in accordance with Commission Decision 2009/770/EC. The EFSA opinion does not justify the imposition of specific conditions or restrictions for the placing on the market and/or specific conditions or restrictions for the use and handling, including post-market monitoring requirements for the use of the food and feed, or of specific conditions for the protection of particular ecosystems/environment and/or geographical areas, as provided for in point (e) of Article 6(5) and Article 18(5) of Regulation (EC) No 1829/2003.

(12) All relevant information on the authorisation of the products should be entered in the Community register of genetically modified food and feed, as provided for in Regulation (EC) No 1829/2003.

(13) This Decision is to be notified through the Biosafety Clearing-House to the Parties to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity, pursuant to Article 9(1) and Article 15(2)(c) of Regulation (EC) No 1946/2003 of the European Parliament and of the Council.

(14) The Standing Committee on the Food Chain and Animal Health has not delivered an opinion within the time limit laid down by its Chairman. An implementing act was deemed to be necessary and the chair submitted the draft implementing act to the appeal committee for further deliberation. The appeal committee did not deliver an opinion,

HAS ADOPTED THIS DECISION:

Article 1 Genetically modified organism and unique identifier

Genetically modified soybean (Glycine max (L.) Merr.) MON87708, as specified in point (b) of the Annex to this Decision, is assigned the unique identifier MON-877Ø8-9, as provided for in Regulation (EC) No 65/2004.

Article 2 Authorisation

The following products are authorised for the purposes of Articles 4(2) and 16(2) of Regulation (EC) No 1829/2003 in accordance with the conditions set out in this Decision:

(a) foods and food ingredients containing, consisting of, or produced from soybean MON-877Ø8-9;

(b) feed containing, consisting of, or produced from soybean MON-877Ø8-9;

(c) soybean MON-877Ø8-9 in products containing it or consisting of it for any other use than (a) and (b), with the exception of cultivation.

Article 3 Labelling

1. For the purposes of the labelling requirements laid down in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003 and in Article 4(6) of Regulation (EC) No 1830/2003, the name of the organism shall be soybean.

2. The words not for cultivation shall appear on the label of and in documents accompanying products containing or consisting of soybean MON-877Ø8-9 with the exception of products referred to in point (a) of Article 2.

Article 4 Monitoring for environmental effects

1. The authorisation holder shall ensure that the monitoring plan for environmental effects, as set out in point (h) of the Annex, is put in place and implemented.

2. The authorisation holder shall submit to the Commission annual reports on the implementation and the results of the activities set out in the monitoring plan in accordance with Decision 2009/770/EC.

Article 5 Community register

The information set out in the Annex to this Decision shall be entered in the Community register of genetically modified food and feed, as provided for in Article 28 of Regulation (EC) No 1829/2003.

Article 6 Authorisation holder

The authorisation holder shall be Monsanto Europe S.A., Belgium, representing Monsanto Company, United States of America.

Article 7 Validity

This Decision shall apply for a period of 10 years from the date of its notification.

Article 8 Addressee

This Decision is addressed to Monsanto Europe S.A., Avenue de Tervuren 270-272, B-1150 Brussels — Belgium.

Done at Brussels, 24 April 2015. For the Commission Vytenis Andriukaitis Member of the Commission

ANNEX

ANNEX

Note: Links to relevant documents may need to be modified over the time. Those modifications will be made available to the public via the updating of the Community register of genetically modified food and feed.

(a) Applicant and Authorisation holder Name Monsanto Europe S.A. Address Avenue de Tervuren 270-272, B-1150 Brussels — Belgium On behalf of Monsanto Company — 800 N. Lindbergh Boulevard — St. Louis, Missouri 63167 — United States of America.

(b) Designation and specification of the products The genetically modified soybean MON-877Ø8-9, as described in the application, expresses the DMO (dicamba mono-oxygenase) proteins which confer tolerance to dicamba-based herbicides.

(b)

(1) foods and food ingredients containing, consisting of, or produced from soybean MON-877Ø8-9;

(2) feed containing, consisting of, or produced from soybean MON-877Ø8-9;

(3) soybean MON-877Ø8-9 in products containing it or consisting of it for any other use than 1 and 2, with the exception of cultivation.

(c) Labelling

(c)

(1) for the purposes of the specific labelling requirements laid down in Articles 13(1) and 25(2) of Regulation (EC) No 1829/2003, and in Article 4(6) of Regulation (EC) No 1830/2003, the name of the organism shall be soybean;

(2) the words not for cultivation shall appear on the label of and in documents accompanying products containing or consisting of soybean MON-877Ø8-9 with the exception of products referred to in point (a) of Article 2.

(d) Method for detection

event-specific real-time PCR based method for the quantification of soybean MON-877Ø8-9,

validated on genomic DNA, extracted from seeds, by the EU Reference Laboratory established under Regulation (EC) No 1829/2003, published at http://gmo-crl.jrc.ec.europa.eu/statusofdossiers.aspx

Reference Material: AOCS 0311-A and AOCS 0906-A are accessible via the American Oil Chemists Society at http://www.aocs.org/tech/crm

(e) Unique identifier MON-877Ø8-9

(f) Information required under Annex II to the Cartagena Protocol on Biosafety to the Convention on Biological Diversity Biosafety Clearing-House, Record ID: see [to be completed when notified].

(g) Conditions or restrictions on the placing on the market, use or handling of the products Not required.

(h) Monitoring plan Monitoring plan for environmental effects conforming with Annex VII to Directive 2001/18/EC. [Link: plan published on the internet]

(i) Post market monitoring requirements for the use of the food for human consumption Not required.

Versions

  1. 2015-04-24

Cited by